Altogether, these observations of GLUT4 have led most authors to conclude that upregulating glucose transporters may be an effective approach to the treatment of insulin resistance and human type 2 diabetes [83, 99–103]. The gene discussed is SLC2A4; the disease is Insulin resistance.